Inoviem Scientific offers a range of services tailored to the needs of drug discovery, preclinical and clinical development. We help researchers better meet all the key requirements to validate an experiment, accelerate drug development or achieve clinical trial objectives.

the Mode of Action of your compound

The ultimate understanding of the Mode of Action (MoA) of your compound resides with taking a patient-centric approach.

Identify and validate targets

Our robust empirical approach enables you to validate targets in a study model, identify secondary targets or validate a target in a targeted organism.

Choose your lead compound for development

With greater emphasis on translational pharmacology, any number of compounds can be profiled, and we can identify within four weeks of study which one of these offers the best ‘druggability’ to move forward into development.

Stratify different patient groups

Inoviem identifies the patient subset that will best respond to the compound.

Define the indication

Should your promising compound fail in its primary indication, we can fast-track you to identifying a condition that would be more efficient.

Identify biomarkers

Inoviem’s translational pharmacology approaches empower your ability to identify promising biomarkers and advance clinical developments.

Bioanalytical services

Inoviem can develop and pre-validate bioanalytical methods according to ICHQ2 guidelines to facilitate your preclinical and clinical phases. We can assist you with all assets you need in order to pursue the pharmaceutical development of your compound.

Need Help